168 related articles for article (PubMed ID: 30776383)
1. Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens.
Whitaker N; Hickey JM; Kaur K; Xiong J; Sawant N; Cupo A; Lee WH; Ozorowski G; Medina-Ramírez M; Ward AB; Sanders RW; Moore JP; Joshi SB; Volkin DB; Dey AK
J Pharm Sci; 2019 Jul; 108(7):2264-2277. PubMed ID: 30776383
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates.
van Schooten J; van Haaren MM; Li H; McCoy LE; Havenar-Daughton C; Cottrell CA; Burger JA; van der Woude P; Helgers LC; Tomris I; Labranche CC; Montefiori DC; Ward AB; Burton DR; Moore JP; Sanders RW; Crotty S; Shaw GM; van Gils MJ
PLoS Pathog; 2021 Aug; 17(8):e1009736. PubMed ID: 34432859
[TBL] [Abstract][Full Text] [Related]
3. Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.
Ringe RP; Pugach P; Cottrell CA; LaBranche CC; Seabright GE; Ketas TJ; Ozorowski G; Kumar S; Schorcht A; van Gils MJ; Crispin M; Montefiori DC; Wilson IA; Ward AB; Sanders RW; Klasse PJ; Moore JP
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487280
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers.
Schorcht A; van den Kerkhof TLGM; Cottrell CA; Allen JD; Torres JL; Behrens AJ; Schermer EE; Burger JA; de Taeye SW; Torrents de la Peña A; Bontjer I; Gumbs S; Ozorowski G; LaBranche CC; de Val N; Yasmeen A; Klasse PJ; Montefiori DC; Moore JP; Schuitemaker H; Crispin M; van Gils MJ; Ward AB; Sanders RW
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999024
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.
Chuang GY; Geng H; Pancera M; Xu K; Cheng C; Acharya P; Chambers M; Druz A; Tsybovsky Y; Wanninger TG; Yang Y; Doria-Rose NA; Georgiev IS; Gorman J; Joyce MG; O'Dell S; Zhou T; McDermott AB; Mascola JR; Kwong PD
J Virol; 2017 May; 91(10):. PubMed ID: 28275193
[TBL] [Abstract][Full Text] [Related]
7. Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers
Ozorowski G; Cupo A; Golabek M; LoPiccolo M; Ketas TA; Cavallary M; Cottrell CA; Klasse PJ; Ward AB; Moore JP
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669838
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers.
de Taeye SW; Go EP; Sliepen K; de la Peña AT; Badal K; Medina-Ramírez M; Lee WH; Desaire H; Wilson IA; Moore JP; Ward AB; Sanders RW
J Biol Chem; 2019 Apr; 294(14):5616-5631. PubMed ID: 30728245
[TBL] [Abstract][Full Text] [Related]
9. Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers.
Ringe RP; Ozorowski G; Rantalainen K; Struwe WB; Matthews K; Torres JL; Yasmeen A; Cottrell CA; Ketas TJ; LaBranche CC; Montefiori DC; Cupo A; Crispin M; Wilson IA; Ward AB; Sanders RW; Klasse PJ; Moore JP
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539451
[TBL] [Abstract][Full Text] [Related]
10. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.
Pugach P; Ozorowski G; Cupo A; Ringe R; Yasmeen A; de Val N; Derking R; Kim HJ; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; Julien JP; Burton DR; Wilson IA; Sanders RW; Klasse PJ; Ward AB; Moore JP
J Virol; 2015 Mar; 89(6):3380-95. PubMed ID: 25589637
[TBL] [Abstract][Full Text] [Related]
11. Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env.
Georgiev IS; Joyce MG; Yang Y; Sastry M; Zhang B; Baxa U; Chen RE; Druz A; Lees CR; Narpala S; Schön A; Van Galen J; Chuang GY; Gorman J; Harned A; Pancera M; Stewart-Jones GB; Cheng C; Freire E; McDermott AB; Mascola JR; Kwong PD
J Virol; 2015 May; 89(10):5318-29. PubMed ID: 25740988
[TBL] [Abstract][Full Text] [Related]
12. Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages.
Behrens AJ; Kumar A; Medina-Ramirez M; Cupo A; Marshall K; Cruz Portillo VM; Harvey DJ; Ozorowski G; Zitzmann N; Wilson IA; Ward AB; Struwe WB; Moore JP; Sanders RW; Crispin M
J Proteome Res; 2018 Mar; 17(3):987-999. PubMed ID: 29420040
[TBL] [Abstract][Full Text] [Related]
13. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
Sanders RW; Derking R; Cupo A; Julien JP; Yasmeen A; de Val N; Kim HJ; Blattner C; de la Peña AT; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; van Gils MJ; King CR; Wilson IA; Ward AB; Klasse PJ; Moore JP
PLoS Pathog; 2013 Sep; 9(9):e1003618. PubMed ID: 24068931
[TBL] [Abstract][Full Text] [Related]
14. Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits.
Yasmeen A; Ringe R; Derking R; Cupo A; Julien JP; Burton DR; Ward AB; Wilson IA; Sanders RW; Moore JP; Klasse PJ
Retrovirology; 2014 May; 11():41. PubMed ID: 24884783
[TBL] [Abstract][Full Text] [Related]
15. Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies.
Chung NP; Matthews K; Kim HJ; Ketas TJ; Golabek M; de Los Reyes K; Korzun J; Yasmeen A; Sanders RW; Klasse PJ; Wilson IA; Ward AB; Marozsan AJ; Moore JP; Cupo A
Retrovirology; 2014 Apr; 11():33. PubMed ID: 24767177
[TBL] [Abstract][Full Text] [Related]
16. Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties.
Guenaga J; de Val N; Tran K; Feng Y; Satchwell K; Ward AB; Wyatt RT
PLoS Pathog; 2015 Jan; 11(1):e1004570. PubMed ID: 25569572
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin.
Ringe RP; Cruz Portillo VM; Dosenovic P; Ketas TJ; Ozorowski G; Nogal B; Perez L; LaBranche CC; Lim J; Francomano E; Wilson IA; Sanders RW; Ward AB; Montefiori DC; Nussenzweig MC; Klasse PJ; Cupo A; Moore JP
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852794
[TBL] [Abstract][Full Text] [Related]
18. Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens.
Schiffner T; de Val N; Russell RA; de Taeye SW; de la Peña AT; Ozorowski G; Kim HJ; Nieusma T; Brod F; Cupo A; Sanders RW; Moore JP; Ward AB; Sattentau QJ
J Virol; 2016 Jan; 90(2):813-28. PubMed ID: 26512083
[TBL] [Abstract][Full Text] [Related]
19. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
[TBL] [Abstract][Full Text] [Related]
20. SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers.
Ringe RP; Colin P; Torres JL; Yasmeen A; Lee WH; Cupo A; Ward AB; Klasse PJ; Moore JP
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
